Mariaelena Capone

14PUBLICATIONS
84CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jul 09, 2025
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma.

Domenico Mallardo, Mario Fordellone, Michael Bailey

|Jan 21, 2025
Role of the androgen receptor in melanoma aggressiveness.

Marzia Di Donato, Costanza Maria Cristiani, Mariaelena Capone

|Nov 27, 2024
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.

Domenico Mallardo, Mario Fordellone, Margaret Ottaviano

|Aug 10, 2024
Innate Immune Cells in Melanoma: Implications for Immunotherapy.

Marialuisa Trocchia, Annagioia Ventrici, Luca Modestino

|Mar 13, 2024
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.

Domenico Liguoro, Rachele Frigerio, Arianna Ortolano

Pageof 3

Frequent Collaborators

11 joint publications

Gabriele Madonna

11 joint publications

Paolo Antonio Ascierto

5 joint publications

Domenico Mallardo

3 joint publications

Alfredo Budillon